Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
How did MoneyWorks4me help subscribers to buy IEX at Rs. 193/ share 1 year before?
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Lincoln Pharmaceuticals Ltd Stock Analysis

Small Cap
Evaluated by 963 users | BSE: 531633 | NSE: LINCOLN |
Pharmaceuticals & Drugs

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on Capital Employed 6.47%8.66%10.3%11.5%13.23%14.04%12.8%16.2%14.73%17.5%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 175192208223311304325353376413432
Y-o-Y Gr. Rt.-9.6%8.8%7.1%39.2%-2.1%6.8%8.6%6.5%9.8%-
Adjusted EPS (Rs.) 1.954.637.28.212.1813.6215.0921.8121.6129.0131.40
Y-o-Y Gr. Rt.-137.4%55.5%13.9%48.5%11.8%10.8%44.5%-0.9%34.2%-
Book Value per Share (Rs.) 49.1654.4760.7768.2780.3994.79109.77131.3152.25182.48191.17
Adjusted Net Profit 3.27.611.713.419.927.230.243.643.25863
Net Op. Cash Flow (Rs. Cr.) 104.39.28.828.917.821.351.170.771.4-
Debt to Cash Flow from Ops 614.135.555.492.092.982.630.660.070.01-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Lincoln Pharmaceuticals Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  10 yrs 5 yrs 3 yrs 1 yr
Net Sales 10%5.9%8.3%9.8%
Adjusted EPS 35%19%24.3%34.2%
Book Value per Share 15.717.818.519.9
Share Price 30.3% 8% 18.1% 69.8%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on Equity (%) 4.068.9412.512.7115.916.5914.7518.0915.2417.3316.81
Operating Profit Margin (%) 7.718.329.1910.4510.5913.9514.2117.1415.9219.7119.66
Net Profit Margin (%) 1.823.945.635.996.398.959.2912.3611.4914.0514.55
Debt to Equity 0.750.690.510.430.460.280.260.130.020-
Working Capital Days 264270272248168198221223227218-
Cash Conversion Cycle 746974108939394908062-
Loading price chart...
Entity Percentage Holding
Promoters 40.28%
Institutions 0.75%
Non-Institutions 58.97%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Lincoln Pharmaceuticals Ltd's earnings have grown by 19%, whereas share price has appreciated 8% CAGR over the past five years, indicating the company’s share price is likely undervalued. However, for specific investment actions please consult your investment advisor.

Lincoln Pharmaceuticals Ltd share price has appreciated 30.3% annually (CAGR) over the past ten years.

Data is not available for this company.

Lincoln Pharmaceuticals was established in 1979 to manufacture and market affordable therapeutic products. Since then, Lincoln Pharmaceuticals has come a long way.

Lincoln Pharmaceuticals is a public limited company with a large shareholder base including members of the medical fraternity. It has its own manufacturing facilities, covering all the major dosage forms, like tablets, capsules, injectables, syrups, Ointments, etc. Its present manufacturing activities are located near Ahmedabad.

Lincoln Pharmaceuticals was established in 1979 to manufacture and market affordable therapeutic products. Since then, Lincoln Pharmaceuticals has come a long way.

Lincoln Pharmaceuticals is a public limited company with a large shareholder base including members of the medical fraternity. It has its own manufacturing facilities, covering all the major dosage forms, like tablets, capsules, injectables, syrups, Ointments, etc. Its present manufacturing activities are located near Ahmedabad. The plant spreads across 30,000 square meters. There are three different buildings for tablets, capsules and injectables and also a separate building for quality control.

An ultramodern laboratory with state-of-the-art equipments ensures in-house quality assurance of each of the products. The products are designed for all therapeutic segments with a special emphasis on gynecological and orthopedic specialties.

Group of Companies

  • Lincoln Parenterals
  • Karnavati Distributors
  • Down Town Travels
  • Shelavi Paper Mills

Product of the company

  • Tablets 
  • Capsules
  • Injectables
  • Syrups
  • Ointments

Certification

  • WHO-GMP standard
  • ISO 9002 certification 
  • Export House certification
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback